Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke
S Frol, J Pretnar Oblak, M Šabovič… - Clinical and Applied …, 2024 - journals.sagepub.com
Direct oral anticoagulants (DOACs) changed stroke prevention and decreased the risk of
ischemic and hemorrhagic complications in patients on oral anticoagulation (OAC) therapy …
ischemic and hemorrhagic complications in patients on oral anticoagulation (OAC) therapy …
Direct Oral Anticoagulants for Pulmonary Embolism
R Pizzi, LA Cimini, W Ageno, C Becattini - Hämostaseologie, 2024 - thieme-connect.com
Venous thromboembolism (VTE) is the third most common cardiovascular disease. For most
patients, the standard of treatment has long consisted on low-molecular-weight heparin …
patients, the standard of treatment has long consisted on low-molecular-weight heparin …
Safety and Outcomes with Direct Oral Anticoagulants Versus Vitamin-K Antagonists in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review, Meta …
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary
hypertension characterized by organized thrombi inside the pulmonary vasculature, leading …
hypertension characterized by organized thrombi inside the pulmonary vasculature, leading …